Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.320 AlteredExpression disease BEFREE This result strongly suggests that amplification of c-erbB-2 occurs frequently in tubular carcinomas in stomach cancer. 3281095 1988
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.320 Biomarker disease CTD_human MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. 22042947 2011
Entrez Id: 5241
Gene Symbol: PGR
PGR 		0.310 AlteredExpression disease BEFREE To examine the levels of estrogen receptor (ER) and progesterone receptor expression in cases of TC and well-differentiated invasive ductal carcinoma as compared to normal breast glands and to determine if any significant differences could be detected via molecular testing. 25357113 2014
Entrez Id: 2099
Gene Symbol: ESR1
ESR1 		0.310 AlteredExpression disease BEFREE To examine the levels of estrogen receptor (ER) and progesterone receptor expression in cases of TC and well-differentiated invasive ductal carcinoma as compared to normal breast glands and to determine if any significant differences could be detected via molecular testing. 25357113 2014
Entrez Id: 4583
Gene Symbol: MUC2
MUC2 		0.310 AlteredExpression disease BEFREE We immunohistochemically examined intratumoural heterogeneity in the expression of Cdx2, MUC2, MUC5AC and MUC6 in 39 intramucosal and 49 extramucosally invasive undifferentiated-type gastric carcinomas (UGCs), consisting of signet ring cell carcinomas showing a layered structure (LS) in the mucosa and dedifferentiated tubular adenocarcinomas without LS and with minor tubular components (TC). 19102008 2008
Entrez Id: 4583
Gene Symbol: MUC2
MUC2 		0.310 Biomarker disease CTD_human Short chain fatty acids and colon cancer. 12468628 2002
Entrez Id: 2099
Gene Symbol: ESR1
ESR1 		0.310 Biomarker disease CTD_human Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. 15639718 2005
Entrez Id: 5241
Gene Symbol: PGR
PGR 		0.310 Biomarker disease CTD_human Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. 15639718 2005
Entrez Id: 2099
Gene Symbol: ESR1
ESR1 		0.310 Biomarker disease CTD_human Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis. 20458558 2011
Entrez Id: 3553
Gene Symbol: IL1B
IL1B 		0.300 Biomarker disease CTD_human Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. 19028472 2009
Entrez Id: 760
Gene Symbol: CA2
CA2 		0.300 Biomarker disease CTD_human Diverse proteomic alterations in gastric adenocarcinoma. 15378696 2004
Entrez Id: 1950
Gene Symbol: EGF
EGF 		0.300 Biomarker disease CTD_human Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells. 23064031 2013
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8 		0.300 Biomarker disease CTD_human Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. 18307536 2008
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1 		0.300 Biomarker disease CTD_human Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. 21472143 2011
Entrez Id: 59340
Gene Symbol: HRH4
HRH4 		0.300 Biomarker disease CTD_human Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression. 22363581 2012
Entrez Id: 56287
Gene Symbol: GKN1
GKN1 		0.300 Biomarker disease CTD_human Diverse proteomic alterations in gastric adenocarcinoma. 15378696 2004
Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1 		0.300 Therapeutic disease CTD_human Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring. 17198089 2007
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.300 Biomarker disease CTD_human Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer. 20430468 2011
Entrez Id: 6934
Gene Symbol: TCF7L2
TCF7L2 		0.300 Biomarker disease CTD_human Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. 21892161 2011
Entrez Id: 1490
Gene Symbol: CCN2
CCN2 		0.300 Biomarker disease CTD_human Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis. 21552421 2011
Entrez Id: 759
Gene Symbol: CA1
CA1 		0.300 Biomarker disease CTD_human Diverse proteomic alterations in gastric adenocarcinoma. 15378696 2004
Entrez Id: 9420
Gene Symbol: CYP7B1
CYP7B1 		0.300 Biomarker disease CTD_human Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. 17639508 2007
Entrez Id: 1548
Gene Symbol: CYP2A6
CYP2A6 		0.300 Biomarker disease CTD_human Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma. 12115524 2002
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.300 Biomarker disease CTD_human Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. 21472143 2011
Entrez Id: 2886
Gene Symbol: GRB7
GRB7 		0.300 Biomarker disease CTD_human Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis. 21552421 2011